Rader reasoned that the expedited generic drug approval process created by the Act required drug testing by the generic manufacturer prior to patent expiration and that § 271 (e) (1) thus covers only ...
On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback